Carnés Jerónimo, Ferrer Angel, Fernández-Caldas Enrique
Laboratorios LETI, SL Research Laboratories, Tres Cantos, Madrid, Spain.
Ann Allergy Asthma Immunol. 2006 Apr;96(4):564-70. doi: 10.1016/S1081-1206(10)63551-X.
More than 100 apple varieties are consumed worldwide. However, the allergenic composition of most apple varieties has not been fully characterized.
To analyze the antigenic and allergenic profiles of 10 different commercially available apple varieties.
Golden, Golden Perlim, Reineta, Reineta Parda, Fuji, Verdedoncella, Granny-Smith, Pink Lady, Royal Gala, and Starking apple varieties were carefully peeled. Peels were individually extracted and centrifuged, and the supernatants were collected, dialyzed, filtered, frozen, and freeze-dried. The extracts were characterized using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblots. Protein content was measured using the Lowry-Biuret method. Twenty-two Spanish patients with oral allergy syndrome after apple ingestion were included in the study. Specific IgE to all apple varieties and birch pollen was evaluated. Eleven patients underwent skin prick testing using extracts of Golden, Starking, and Reineta Parda varieties to determine differences in their in vivo allergenicity.
The antigenic profile of the 10 varieties showed differences using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A 9-kDa band, which could correspond to Mal d 3, was visualized in all the extracts. The Starking variety had the highest protein content. Higher specific IgE values were also obtained for the Starking variety, and the lowest values were for Reineta Parda and Royal Gala. The largest wheals were obtained in all patients with the Starking variety, and the smallest with Reineta Parda. Fourteen patients (64%) recognized Mal d 3 in the Golden variety using immunoblots; 6 patients (27%), who also had specific IgE to Betula, recognized bands with higher molecular weights.
We demonstrated differences in the antigenic and allergenic profiles of the analyzed varieties and a significant variation in Mal d 3 content.
全球消费的苹果品种超过100种。然而,大多数苹果品种的致敏成分尚未得到充分表征。
分析10种不同市售苹果品种的抗原和致敏谱。
仔细剥去金冠、金珀林、雷内塔、帕达雷内塔、富士、韦尔德东塞拉、澳洲青苹、粉红女士、皇家嘎拉和斯塔克苹果品种的外皮。将外皮单独提取并离心,收集上清液,进行透析、过滤、冷冻和冻干。使用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和免疫印迹对提取物进行表征。采用洛瑞-双缩脲法测定蛋白质含量。本研究纳入了22名食用苹果后出现口腔过敏综合征的西班牙患者。评估了对所有苹果品种和桦树花粉的特异性IgE。11名患者使用金冠、斯塔克和帕达雷内塔品种的提取物进行皮肤点刺试验,以确定它们体内致敏性的差异。
使用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳显示,10个品种的抗原谱存在差异。在所有提取物中均可见一条可能对应于Mal d 3的9 kDa条带。斯塔克品种的蛋白质含量最高。斯塔克品种的特异性IgE值也更高,而帕达雷内塔和皇家嘎拉的特异性IgE值最低。所有患者使用斯塔克品种时出现的风团最大,使用帕达雷内塔品种时风团最小。14名患者(64%)通过免疫印迹在金冠品种中识别出Mal d 3;6名患者(27%)同时对桦树有特异性IgE,识别出分子量更高的条带。
我们证明了所分析品种的抗原和致敏谱存在差异,且Mal d 3含量存在显著差异。